LungLife AI, Inc. announced that it has received $315,780 in funding on March 22, 2024. The company issued common shares in the transaction. The company issued securities pursuant to exemption provided under Regulation D. The transaction included participation from eight investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16 GBX | 0.00% | 0.00% | -65.22% |
05/04 | Transcript : LungLife AI, Inc., 2023 Earnings Call, Apr 05, 2024 | |
04/04 | LungLife reports narrowed losses in year of "considerable achievement" | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-65.22% | 6.2M | |
-42.65% | 7.8B | |
+4.47% | 3.53B | |
-0.86% | 2.24B | |
-26.79% | 1.84B | |
-22.46% | 1.66B | |
+5.95% | 951M | |
+28.17% | 811M | |
-7.86% | 670M | |
-26.53% | 533M |
- Stock Market
- Equities
- LLAI Stock
- News LungLife AI, Inc.
- LungLife AI, Inc. announced that it has received $0.31578 million in funding